Menu
 

Search abstracts


Clinical pharmacokinetics of amikacin in premature neonates.

  • At: 2007 FIP Congress in Beijing (China)
  • Type: Poster
  • By: CACERES GUIDO, Paulo Arturo (Hospital de Pediatria Garrahan, Buenos Aires, Argentina)
  • Co-author(s): Travaglianti, Monica (Hospital de Pediatria Garrahan, BUENOS AIRES, Argentina)
    Castro, Graciela (Hospital de Pediatria Garrahan, BUENOS AIRES, Argentina)
    Moroni, Alicia (Hospital de Pediatria Garrahan, BUENOS AIRES, Argentina)
    Díaz, A (Hospital de Pediatria Garrahan, BUENOS AIRES, Argentina)
    Licciardone, Nieves (Hospital de Pediatria Garrahan, BUENOS AIRES, Argentina)
    Ferreira, Oscar (Hospital de Pediatria Garrahan, BUENOS AIRES, Argentina)
    Currás, Verónica (Facultad de Farmacia y Bioquímica (UBA), BUENOS AIRES, Argentina)
    Bramuglia, Guillermo (Facultad de Farmacia y Bioquímica (UBA), BUENOS AIRES, Argentina)
  • Abstract:

    Aims: amikacin (AMK) is an aminoglycoside antibiotic used in premature neonates to treat suspected or confirmed Gram (â€') bacilli infections. Our goal was to estimate AMK pharmacokinetic (PK) parameters and to calculate suitable dose schemes for inpatient premature neonates. We considered prematures to neonates with gestational age (GA) less..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses